BIOPHTA

About:

BIOPHTA has pioneered a novel approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery.

Website: https://www.biophta.com

Top Investors: UI Investissement, Elaia, GO CAPITAL, Unither Pharmaceuticals, HTL Biotechnology

Description:

BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management.

Total Funding Amount:

6.5M EUR

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2020-01-01

Founders:

Jean Cuiné, Jean Garrec

Number of Employees:

1-10

Last Funding Date:

2024-06-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai